BEVATEM: Phase II single-center study of bevacizumab in combination with temozolomide in patients (pts) with first-line metastatic uveal melanoma (MUM): First-step results.
暂无分享,去创建一个
V. Servois | L. Desjardins | B. Asselain | F. Bidard | S. Piperno-Neumann | P. Mariani | C. Plancher | Nora Vago-Ady